Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Elevance Health $2.6 billion senior notes offering
The investment-grade notes are due 2026, 2033 and 2053
Morgan Stanley AIP closes $2.5 billion secondaries fund
We advised Morgan Stanley AIP on the transaction
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Central American Bank for Economic Integration $1.25 billion social notes
The 5.000% senior notes are due 2026
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
IBM $3.25 billion, €4.25 billion and £750 million notes offering
The investment-grade debt consists of nine tranches of notes
Invacare chapter 11 filing
We are advising Highbridge Capital in connection with the restructuring
Integer Holdings $500 million convertible senior notes offering
The 2.125% convertible notes are due 2028
Constellation Brands $500 million senior notes offering
The investment-grade notes are due 2026
Norwegian Cruise Line $600 million senior secured notes offering
The senior secured notes are due 2028